HUP9800377A1 - Új növekedési faktor és ezt kódoló génszekvencia - Google Patents

Új növekedési faktor és ezt kódoló génszekvencia

Info

Publication number
HUP9800377A1
HUP9800377A1 HU9800377A HUP9800377A HUP9800377A1 HU P9800377 A1 HUP9800377 A1 HU P9800377A1 HU 9800377 A HU9800377 A HU 9800377A HU P9800377 A HUP9800377 A HU P9800377A HU P9800377 A1 HUP9800377 A1 HU P9800377A1
Authority
HU
Hungary
Prior art keywords
growth factor
sequence encoding
genetic sequence
needle
encoding same
Prior art date
Application number
HU9800377A
Other languages
English (en)
Inventor
Sean Grimmond
Nicholas Kim Hayward
Catharina Larsson
Magnus Nordenskjold
Gunther Weber
Original Assignee
Amrad Operations Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty. Ltd. filed Critical Amrad Operations Pty. Ltd.
Publication of HUP9800377A1 publication Critical patent/HUP9800377A1/hu
Publication of HUP9800377A3 publication Critical patent/HUP9800377A3/hu
Publication of HU223438B1 publication Critical patent/HU223438B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány általánősan egy vaszkűláris endőteliális növekedésifaktőrszerű tűlajdőnságőkkal rendelkező izőlált mőlekűlára és egy eztkódőló génszekvenciára vőnatkőzik. A mőlekűla számős, növelt vagycsökkent érrendszeri és/vagy vaszkűláris permeabilitást igénylőállapőtők kezelésében, megelőzésében és/vagy diagnősztizálásábanhasználatős terápiás készítmény és diagnősztikűm kifejlesztésébenhasznősítható. A találmány szerinti mőlekűla a primer és a közpőntineűrőnők hasznős effektőra, és képes asztrőglia prőliferációt iskiváltani. A találmány a fenti tűlajdőnságú rekőmbináns mőlekűla előállítására,és a mőlekűlát tartalmazó gyógyszerkészítményre is vőnatkőzik. ŕ
HU9800377A 1995-03-02 1996-02-22 Új növekedési faktor és ezt kódoló génszekvencia HU223438B1 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same

Publications (3)

Publication Number Publication Date
HUP9800377A1 true HUP9800377A1 (hu) 1998-06-29
HUP9800377A3 HUP9800377A3 (en) 2000-12-28
HU223438B1 HU223438B1 (hu) 2004-07-28

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800377A HU223438B1 (hu) 1995-03-02 1996-02-22 Új növekedési faktor és ezt kódoló génszekvencia

Country Status (16)

Country Link
US (1) US20070135344A1 (hu)
EP (1) EP0815221B1 (hu)
JP (2) JPH11500139A (hu)
KR (1) KR100414615B1 (hu)
CN (1) CN1194090C (hu)
AT (1) ATE252600T1 (hu)
BR (1) BR9607628A (hu)
CA (1) CA2214439C (hu)
DE (1) DE69630442T2 (hu)
ES (1) ES2206558T3 (hu)
FI (1) FI120153B (hu)
HK (1) HK1002963A1 (hu)
HU (1) HU223438B1 (hu)
NO (1) NO320839B1 (hu)
NZ (2) NZ337634A (hu)
WO (1) WO1996027007A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
EP0873348A4 (en) * 1995-06-06 2000-11-08 Human Genome Sciences Inc GROWTH FACTOR 3 OF THE HUMAN VASCULAR ENDOTHELIUM
DE69628652T3 (de) 1995-09-08 2012-05-03 Genentech, Inc. Vegf-verwandtes protein
AU7142996A (en) 1995-09-29 1997-04-28 Universita' Degli Studi Di Siena Regulated genes and uses thereof
AU1116297A (en) 1995-11-08 1997-05-29 Immunex Corporation Flk-1 binding protein
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
ATE306546T1 (de) 1996-08-23 2005-10-15 Ludwig Inst Cancer Res Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d)
IL132537A0 (en) * 1997-04-25 2001-03-19 Collateral Therapeutics Truncated vegf-related proteins
CN1295617A (zh) 1998-02-06 2001-05-16 科莱特诺医疗公司 血管生成因子－血管内皮细胞生长因子vegf的突变体
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
WO2000027879A1 (en) * 1998-11-10 2000-05-18 Ludwig Institute For Cancer Research Platelet-derived growth factor d, dna coding therefor, and uses thereof
CA2354325C (en) 1998-12-07 2011-08-16 Zymogenetics, Inc. Growth factor homolog zvegf3
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
WO2002046412A2 (en) 2000-12-07 2002-06-13 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
WO2006094106A2 (en) 2005-02-28 2006-09-08 Sangamo Biosciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf－r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
JPH09510093A (ja) * 1994-03-08 1997-10-14 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 血管内皮細胞増殖因子２
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor

Also Published As

Publication number Publication date
DE69630442T2 (de) 2004-08-19
NZ301611A (en) 2000-02-28
CN1224464A (zh) 1999-07-28
CA2214439C (en) 2002-12-17
JPH11500139A (ja) 1999-01-06
CA2214439A1 (en) 1996-09-06
FI120153B (fi) 2009-07-15
ES2206558T3 (es) 2004-05-16
HUP9800377A3 (en) 2000-12-28
JP2001037493A (ja) 2001-02-13
EP0815221A4 (en) 1998-12-09
US20070135344A1 (en) 2007-06-14
ATE252600T1 (de) 2003-11-15
HU223438B1 (hu) 2004-07-28
KR100414615B1 (ko) 2004-05-27
FI973571A (fi) 1997-10-30
FI973571A0 (fi) 1997-09-01
JP3683778B2 (ja) 2005-08-17
EP0815221B1 (en) 2003-10-22
WO1996027007A1 (en) 1996-09-06
HK1002963A1 (en) 1998-09-30
CN1194090C (zh) 2005-03-23
KR19980702702A (ko) 1998-08-05
NO320839B1 (no) 2006-01-30
DE69630442D1 (de) 2003-11-27
NZ337634A (en) 2001-06-29
BR9607628A (pt) 1999-11-30
EP0815221A1 (en) 1998-01-07
NO974035D0 (no) 1997-09-02
NO974035L (no) 1997-11-03

Similar Documents

Publication Publication Date Title
HUP9800377A1 (hu) Új növekedési faktor és ezt kódoló génszekvencia
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
EP0831885A4 (en) METHODS OF USING THE CONNECTIVE TISSUE GROWTH FACTOR AS AN INDUCING AGENT
ATE205254T1 (de) Transformierender wachstumsfaktor alpha h1
HUP0103758A2 (hu) Neurotróf faktorok
AUPN568095A0 (en) Anti-Galalpha(1,3)Gal antibody binding peptides
EP0751992A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
AU1724795A (en) Human tissue inhibitor of metalloproteinase-4
HUP0103598A2 (hu) Készítmények és eljárások WT1-specifikus immunterápiás alkalmazásra
NZ271756A (en) Human macrophage inflammatory proteins and coding sequences, their production and use
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
NO973685L (no) Multi-tumor avvikende vekstgener
HUP9902429A2 (hu) TNF-receptor-asszociált faktor (TRAF) modulátorok előállítása és alkalmazása
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
HUP9800260A1 (hu) Eljárás rekombináns adenovírus előállítására és génterápiai alkalmazása
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk
DE69730967D1 (en) Human dnase ii
EP0780472A3 (en) Stress proteins
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
UA66749C2 (en) Actin-resistant variants of human dnase i, isolated nucleic acid, a method for treatment of patients suffering from pulmonary diseases

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20040510